MAURI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 3.631
EU - Europa 2.509
AS - Asia 1.021
SA - Sud America 107
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 7.290
Nazione #
US - Stati Uniti d'America 3.578
IT - Italia 922
SG - Singapore 418
DE - Germania 413
IE - Irlanda 277
CN - Cina 270
SE - Svezia 207
RU - Federazione Russa 154
HK - Hong Kong 134
GB - Regno Unito 120
BR - Brasile 93
AT - Austria 87
UA - Ucraina 72
ID - Indonesia 69
FI - Finlandia 57
FR - Francia 57
CA - Canada 51
DK - Danimarca 40
IN - India 34
VN - Vietnam 29
NL - Olanda 24
TR - Turchia 23
CZ - Repubblica Ceca 19
BE - Belgio 18
ES - Italia 12
JP - Giappone 9
AR - Argentina 6
EU - Europa 6
TW - Taiwan 5
IR - Iran 4
KR - Corea 4
LT - Lituania 4
NO - Norvegia 4
PE - Perù 4
RO - Romania 4
AZ - Azerbaigian 3
BD - Bangladesh 3
BG - Bulgaria 3
HU - Ungheria 3
MA - Marocco 3
PK - Pakistan 3
PT - Portogallo 3
SC - Seychelles 3
AL - Albania 2
AU - Australia 2
EE - Estonia 2
IQ - Iraq 2
KG - Kirghizistan 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
OM - Oman 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CH - Svizzera 1
CY - Cipro 1
EC - Ecuador 1
EG - Egitto 1
GT - Guatemala 1
KE - Kenya 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
TG - Togo 1
TZ - Tanzania 1
Totale 7.290
Città #
Ann Arbor 1.290
Milan 344
Singapore 336
Frankfurt am Main 302
Dublin 272
Chandler 228
Wilmington 225
Fairfield 186
Woodbridge 179
Ashburn 151
Hong Kong 132
Dearborn 119
Houston 117
Santa Clara 112
New York 84
Vienna 80
Jacksonville 71
Jakarta 69
Seattle 59
Princeton 57
Cambridge 55
Shanghai 48
Nanjing 38
Helsinki 36
Altamura 31
Beijing 26
Lawrence 23
Munich 23
Monza 21
Nuremberg 19
Rome 19
Brussels 18
Council Bluffs 18
Fremont 18
Carate Brianza 17
Guangzhou 17
Los Angeles 16
Como 15
San Diego 15
Shenyang 14
Boardman 13
Lachine 13
Nanchang 13
Toronto 13
Kunming 12
London 12
Meda 12
Romola 12
Brno 11
Jinan 11
Dong Ket 10
Genoa 10
Ottawa 10
Washington 10
Cinisello Balsamo 9
Desio 9
Edmonton 9
Falls Church 9
Lissone 9
Paris 9
Sesto San Giovanni 9
São Paulo 9
Turin 9
Chicago 8
Hangzhou 8
Lodi 8
Pune 8
Kocaeli 7
Mountain View 7
Norwalk 7
Riva del Garda 7
Seregno 7
Andover 6
Dallas 6
Florence 6
Hebei 6
Jiaxing 6
Naples 6
Redmond 6
Sacramento 6
Segrate 6
Tianjin 6
Bonndorf 5
Grafing 5
Kiev 5
Kilburn 5
Ningbo 5
Novara 5
Pavia 5
San Mateo 5
Agrate Brianza 4
Bari 4
Cagliari 4
Cesena 4
Créteil 4
Hamburg 4
Kaohsiung 4
Lappeenranta 4
Lima 4
Torino 4
Totale 5.350
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 408
Impaired thromboxane receptor dimerization reduces signaling efficiency: A potential mechanism for reduced platelet function in vivo 362
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 361
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 314
Plasma membrane cholesterol level and agonist-induced internalization of δ-opioid receptors; colocalization study with intracellular membrane markers of Rab family 307
A novel high-content immunofluorescence assay as a tool to identify at the single cell level γ-globin inducing compounds 298
Light on the structure of thromboxane A2 receptor heterodimers 287
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 281
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 269
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 268
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 265
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 250
Hif1a: A putative modifier of hemochromatosis 223
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib 214
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 212
Mitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling 208
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution 198
Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series 183
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 174
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 166
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 144
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 144
Cellule staminali mesenchimali: potenziali modulatori del sistema nervoso centrale 141
CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL 136
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 134
Mesenchymal stem cells enhance GABAergic trasmission in co-coltured hippocampal neurons 130
Superactive mutants of thromboxane prostanoid receptor: functional and computational analysis of an active form alternative to constitutively active mutants 114
Idiopathic erythrocytosis: a germline disease? 113
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 113
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 108
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution 101
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 98
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 92
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis 84
null 83
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 72
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 71
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 69
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 67
Flavonoids-Enriched Vegetal Extract Prevents the Activation of NFκB Downstream Mechanisms in a Bowel Disease In Vitro Model 57
Role of somatic ETNK1 mutation in the mitochondrial activity 56
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 53
Analysis of GPCR dimerization using acceptor photobleaching resonance energy transfer techniques. 44
Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells 43
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 41
ETNK1 mutations increase mitochondrial activity and promote DNA damage through ROS production 40
PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES 35
Correction to: Antibody Deficiency in Patients with Biallelic KARS1 Mutations (Journal of Clinical Immunology, (2023), 43, 8, (2115-2125), 10.1007/s10875-023-01584-7) 34
Antibody Deficiency in Patients with Biallelic KARS1 Mutations 34
ActivinA modulates B-acute lymphoblastic leukaemia cell communication and survival by inducing extracellular vesicles production 27
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 19
Totale 7.745
Categoria #
all - tutte 26.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.560


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020320 0 0 0 0 0 0 0 63 71 93 70 23
2020/20211.326 34 44 91 124 106 105 175 140 124 130 120 133
2021/2022775 100 97 93 68 55 66 17 25 31 40 78 105
2022/20231.125 115 296 109 115 77 145 27 50 64 30 36 61
2023/20241.097 37 37 44 84 117 267 194 49 90 42 27 109
2024/20251.623 113 266 227 170 276 211 268 92 0 0 0 0
Totale 7.745